Excipients have a significant impact on the manufacturability and pharmaceutical performance of pharmaceutical formulations. Therefore, it is important to identify and control the Functionality-Related Characteristics (FRCs) of excipients in order to obtain safe, robust and stable products. However, in most cases, the limited information available on an excipient Certificate of Analysis (COA) has little effect on interpreting observed formulation properties or finding product-specific FRCs. Reverse engineering of excipients refers to the process of determining the specific identity and exact quantity of each component by breaking down a drug product formulation into separate components.
At BOC Sciences, the combination of our experts' knowledge of excipient properties and our specialized analytical laboratory facilities, methods and procedures, allows us to provide quantification of excipients and identification of individual excipients in drug formulations.
Figure 1. Schematic diagram of reverse-engineering approaches to drug discovery. (Ambesi, A.; Di Bernardo, D. 2006)
For certain excipients, we have analyzed up to one hundred unique batches of different suppliers to expand our knowledge database. Our years of experience in excipient characterization have allowed us to not only identify and quantify individual excipients in drug products, but also to reveal and compare hidden excipient properties:
Figure 2. Application of reverse engineering in the field of pharmaceutical tablets using Raman mapping. (Čapková, T.;et al.2022)
References